EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prevalence and clinicopathological features of primary age‐related tauopathy (PART): A large forensic autopsy study

Koji Yoshida, Yukiko Hata, Shojiro Ichimata, Ryo Tanaka, Naoki Nishida iD

Alzheimer's & Dementia · 2024

DOI: 10.1002/alz.14037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2024. Verfasst von Koji Yoshida und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Legal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan. Hauptthemen laut MEDLINE: Tauopathies, Autopsy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Primary age‐related tauopathy (PART), often regarded as a minimally symptomatic pathology of old age, lacks comprehensive cohorts across various age groups. METHODS We examined PART prevalence and clinicopathologic features in 1589 forensic autopsy cases (≥40 years old, mean age ± SD 70.2 ± 14.2 years). RESULTS PART cases meeting criteria for argyrophilic grain diseases (AGD) were AGD+PART ( n = 181). The remaining PART cases ( n = 719, 45.2%) were classified as comorbid conditions (PART‐C, n = 90) or no comorbid conditions (pure PART, n = 629). Compared to controls ( n = 208), Alzheimer's disease ( n = 133), and AGD+PART, PART prevalence peaked in the individuals in their 60s (65.5%) and declined in the 80s (21.5%). No significant clinical background differences were found (excluding controls). However, PART‐C in patients inclusive of age 80 had a higher suicide rate than pure PART ( p < 0.05), and AGD+PART showed more dementia ( p < 0.01) and suicide ( p < 0.05) than pure PART. DISCUSSION Our results advocate a reevaluation of the PART concept and its diagnostic criteria. Highlights We investigated 1589 forensic autopsy cases to investigate the features of primary age‐related tauopathy (PART). PART peaked in people in their 60s in our study. Many PART cases over 80s had comorbid pathologies in addition to neurofibrillary tangles pathology. Argyrophilic grain disease and Lewy pathology significantly affected dementia and suicide rates in PART. Our results suggest that the diagnostic criteria of PART need to be reconsidered.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TauopathiesAutopsyHumansMaleFemaleAgedPrevalenceAged, 80 and overMiddle AgedAdultAlzheimer DiseaseBrainAgingComorbidity

Stichwörter der Autor:innen

Alzheimer's diseaseLewy body diseaseagingargyrophilic grain diseasedementiaprimary age‐related tauopathysuicide

Autor:innen und Institutionen

  • Department of Legal Medicine, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Tanz Centre for Research in Neurodegenerative Disease, Krembil Discovery Tower, University of Toronto, Toronto, Ontario, Canada.
  • Department of Laboratory Medicine and Pathobiology and Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Department of Neurology, Toyama University Hospital, Toyama, Japan.

ORCID-Profile: Naoki Nishida

Förderung

  • JSPS KAKENHI

Zitieren

APA

Yoshida, K., Hata, Y., Ichimata, S., Tanaka, R., & Nishida, N. (2024). Prevalence and clinicopathological features of primary age‐related tauopathy (PART): A large forensic autopsy study. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14037

Vancouver

Yoshida K, Hata Y, Ichimata S, Tanaka R, Nishida N. Prevalence and clinicopathological features of primary age‐related tauopathy (PART): A large forensic autopsy study. Alzheimer's & Dementia. 2024. doi:10.1002/alz.14037

BibTeX
@article{Yoshida2024,
  author = {Yoshida, Koji and Hata, Yukiko and Ichimata, Shojiro and Tanaka, Ryo and Nishida, Naoki},
  title = {Prevalence and clinicopathological features of primary age‐related tauopathy (PART): A large forensic autopsy study},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  doi = {10.1002/alz.14037}
}
Kostenlos starten →